Ann Koehler, MD
Dermatology · Burnsville, MNNPI 1700820073
Payments from drug & device makers
Across 14 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$50
- Medline Industries LP$43
- Regeneron Healthcare Solutions, Inc.$37
- DUSA Pharmaceuticals, Inc.$34
- UCB, Inc.$25
- Galderma Laboratories, L.p.$24
- plus $45 from 3 others
What the payments were for
- Food & beverage$24394%
- Education$156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 3 | $50 |
| Medline Industries LP | 1 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| DUSA Pharmaceuticals, Inc. | 2 | $34 |
| UCB, Inc. | 1 | $25 |
| Galderma Laboratories, L.p. | 2 | $24 |
| Bristol Myers Squibb | 1 | $18 |
| Amgen | 1 | $15 |
| Dermira, Inc. | 1 | $12 |
How this compares
$258 in reported general payments places this provider in the 55th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $145,724 |
| Humira PenAdalimumab | 13 | $85,751 |
| Fluorouracil | 57 | $3,624 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 67 | $2,783 |
| Metronidazole | 23 | $2,159 |
| Calcipotriene | 12 | $1,478 |
| Ketoconazole | 69 | $1,369 |
| Fluocinonide | 18 | $898 |
| Clindamycin Phosphate | 17 | $650 |
| Clobetasol Propionate | 19 | $603 |
| Hydroxychloroquine Sulfate | 13 | $568 |
| Triamcinolone Acetonide | 51 | $518 |
| ValacyclovirValacyclovir Hcl | 12 | $299 |
| Mometasone Furoate | 12 | $257 |
| Hydroxyzine Hcl | 15 | $249 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Burnsville
- Heidi FosterBurnsville$1K
- Steven KempersFridley$5.1M
- Maria HordinskyMinneapolis$2.1M
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$456K
- Afsaneh AlaviRochester$440K
- Noah GoldfarbMinneapolis$359K
- Michael CamilleriRochester$297K
- Megha TollefsonRochester$243K
- Paul BigliardiMinneapolis$237K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.